Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering easier manufacturing and storage, though it may cause more side effects. A once-daily pill now in late-stage testing could push weight loss treatment into a new era. The drug, called orforglipron, is showing stronger results […]
Nearly 1 in 5 Gray Whales That Enter San Francisco Bay Die There
Gray whales are turning to San Francisco Bay for survival, but for many, it’s a fatal detour. Gray whales are famous for their long migration between Arctic feeding grounds and the warm lagoons of Baja Mexico. But as climate change reshapes ocean ecosystems, these whales are beginning to behave in unexpected ways. Some have recently […]
Nearly 1 in 5 Gray Whales That Enter San Francisco Bay Die There
Gray whales are turning to San Francisco Bay for survival, but for many, it’s a fatal detour. Gray whales are famous for their long migration between Arctic feeding grounds and the warm lagoons of Baja Mexico. But as climate change reshapes ocean ecosystems, these whales are beginning to behave in unexpected ways. Some have recently […]
Nearly 1 in 5 Gray Whales That Enter San Francisco Bay Die There
Gray whales are turning to San Francisco Bay for survival, but for many, it’s a fatal detour. Gray whales are famous for their long migration between Arctic feeding grounds and the warm lagoons of Baja Mexico. But as climate change reshapes ocean ecosystems, these whales are beginning to behave in unexpected ways. Some have recently […]
The Ozone Layer Is Healing, But There’s a Hidden Catch
A hidden chemical leak may be quietly delaying the ozone layer’s comeback. The Montreal Protocol, signed in 1987, is widely considered one of the most effective environmental agreements ever implemented. It has driven a global phaseout of chemicals that once damaged the ozone layer and increased risks such as skin cancer and other health problems. […]
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
A new approach to treating certain bowel cancers is showing long-lasting effects. Patients with a particular form of bowel cancer have remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, rather than chemotherapy afterward. These findings come from the NEOPRISM-CRC clinical trial led by researchers at UCL and UCLH. […]
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
A new approach to treating certain bowel cancers is showing long-lasting effects. Patients with a particular form of bowel cancer have remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, rather than chemotherapy afterward. These findings come from the NEOPRISM-CRC clinical trial led by researchers at UCL and UCLH. […]
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
A new approach to treating certain bowel cancers is showing long-lasting effects. Patients with a particular form of bowel cancer have remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, rather than chemotherapy afterward. These findings come from the NEOPRISM-CRC clinical trial led by researchers at UCL and UCLH. […]
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
A new approach to treating certain bowel cancers is showing long-lasting effects. Patients with a particular form of bowel cancer have remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, rather than chemotherapy afterward. These findings come from the NEOPRISM-CRC clinical trial led by researchers at UCL and UCLH. […]
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
A new approach to treating certain bowel cancers is showing long-lasting effects. Patients with a particular form of bowel cancer have remained cancer-free for nearly three years after receiving a short course of immunotherapy before surgery, rather than chemotherapy afterward. These findings come from the NEOPRISM-CRC clinical trial led by researchers at UCL and UCLH. […]